Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict no Recurrence of Stage I Adenocarcinoma Lung Cancer

Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal... ORIGINAL ARTICLE Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict no Recurrence of Stage I Adenocarcinoma Lung Cancer Kosuke Kashiwabara, MD, Syoh Saeki, MD, Ji-ichiro Sasaki, MD, Masanobu Nomura, MD, and Hirotsugu Kohrogi, MD ccording to the 2007 American College of Chest Physi- Study Objectives: It has been reported that high levels of serum Acians guidelines for diagnosis and management for lung carcinoembryonic antigen (CEA) after surgery, or the presence of cancer, for both stage IA and IB non-small cell lung cancer vascular invasion or both, are strong indicators of postoperative (NSCLC) patients who had the curative resection, adjuvant recurrence in patients with non-small cell lung cancer. The chemotherapy has not been recommended for routine use. In purpose of this study is to evaluate which kind of patients with Japan, oral uracil/tegafur (UFT) therapy is performed as p-stage I adenocarcinoma need adjuvant chemotherapy, using adjuvant chemotherapy in pathologic (p-) stage IB adenocar- those predictors. cinoma patients because it has been reported that a 5-year Patients and Methods: We studied 136 patients with curatively survival rate is 85% in the UFT group compared with 74% http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict no Recurrence of Stage I Adenocarcinoma Lung Cancer

Kohrogi, Hirotsugu
Journal of Thoracic Oncology , Volume 3 (12) – Dec 1, 2008
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/combined-evaluation-of-postoperative-serum-levels-of-carcinoembryonic-PRC2SAKzMo

References (26)

ISSN
1556-0864
DOI
10.1097/JTO.0b013e31818dda85
pmid
19057266
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict no Recurrence of Stage I Adenocarcinoma Lung Cancer Kosuke Kashiwabara, MD, Syoh Saeki, MD, Ji-ichiro Sasaki, MD, Masanobu Nomura, MD, and Hirotsugu Kohrogi, MD ccording to the 2007 American College of Chest Physi- Study Objectives: It has been reported that high levels of serum Acians guidelines for diagnosis and management for lung carcinoembryonic antigen (CEA) after surgery, or the presence of cancer, for both stage IA and IB non-small cell lung cancer vascular invasion or both, are strong indicators of postoperative (NSCLC) patients who had the curative resection, adjuvant recurrence in patients with non-small cell lung cancer. The chemotherapy has not been recommended for routine use. In purpose of this study is to evaluate which kind of patients with Japan, oral uracil/tegafur (UFT) therapy is performed as p-stage I adenocarcinoma need adjuvant chemotherapy, using adjuvant chemotherapy in pathologic (p-) stage IB adenocar- those predictors. cinoma patients because it has been reported that a 5-year Patients and Methods: We studied 136 patients with curatively survival rate is 85% in the UFT group compared with 74%

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Dec 1, 2008

There are no references for this article.